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ABSTRACT
Nucleotide composition varies greatly among DNA
viruses of animals, yet the evolutionary pressures
and biological mechanisms driving these patterns
are unclear. One of the most striking discrepancies
lies in the frequency of CpG (the dinucleotide CG,
linked by a phosphate group), which is under-
represented in most small DNA viruses (those with
genomes below 10kb) but not in larger DNA viruses.
Cytosine methylation might be partially responsible,
but research on this topic has focused on a few
virus groups. For several viruses that integrate their
genome into the host genome, the methylation
status during this stage has been studied exten-
sively, and the relationship between methylation and
viral-induced tumor formation has been examined
carefully. However, for actively replicating viruses—
particularly small DNA viruses—the methylation
status of CpG motifs is rarely known and the
effects on the viral life cycle are obscure. In
vertebrate host genomes, most cytosines at CpG
sites are methylated, which in vertebrates acts to
regulate gene expression and facilitates the recog-
nition of unmethylated, potentially pathogen-
associated DNA. Here we briefly introduce cytosine
methylation before reviewing what is currently
known about CpG methylation in DNA viruses.
INTRODUCTION
CpG underrepresentation in vertebrate genomes
The denotation ‘CpG’ is shorthand for the occurrence of a
cytosine linked, through a phosphate bond, to a guanine.
CpGs are underrepresented in most eukaryote genomes,
but the frequency varies widely among species and is
negatively correlated with the presence and extend of
cytosine methylation in the genome (1,2). In vertebrate
genomes, CpGs are present at one-third to one-fourth of
the expected frequency, yet the reasons are disputed (1–4).
Cytosine and guanine tend to have higher stacking
energies than adenine and thymine, so structural con-
strains may be important in CpG avoidance (5). In many
species, the proportion of tRNAs containing CpG in their
anticodons is lower than that of tRNAs with other
dinucleotides; therefore, the transcription eﬃciency might
be higher for codons not containing CpGs (6). Another
explanation may lie in the fact that unmethylated CpGs
can stimulate innate immune responses, potentially
resulting in autoimmune reactions (7–9); therefore, large
numbers of CpGs may be detrimental if not all are
methylated. Finally, methylated cytosines have a tendency
for spontaneous deamination, which may also account
for the CpG depletion (10–12). While the deamination
of unmethylated cytosines leads to uracil and can be
corrected by cellular DNA repair machinery, the transi-
tion of methylated cytosines to thymines is irreversible,
leading to elevated mutation frequencies in highly
methylated genomes.
In general, vertebrate genomic CpGs are highly
methylated. Sixty to 90% of genomic CpGs are thought
to be in a methylated state (13,14), but both CpG
frequency and methylation patterns can vary widely
across a single vertebrate genome. Notably, some regions
are CpG-enriched yet practically devoid of methylation.
These sequence stretches, termed ‘CpG islands’, are
>500bp in length and comprise  1% of total genomic
DNA [e.g. the human genome contains more than 29000
such islands, with estimates reaching as high as 45000
islands per haploid genome (15,16)]. The islands are often
associated with 50 promoter regions of housekeeping genes
[for reviews see, among others, (15,17,18)].
Vertebrate CpG methyltransferases
Vertebrate genomes are methylated by DNA methyl-
transferases (DNMTs) which convert cytosine to
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ally divided into ‘de novo’ (DNMT3a and DNMT3b) and
‘maintenance’ (DNMT1) methyltransferases (Table 1).
Their catalytic domains appear highly conserved across
species and S-adenosyl methionine (SAM) appears to
function as the only methyl donor [reviews of mammalian
DNA methyltransferases can be found in (19–22)].
DNMT expression levels in nontransformed tissues have
rarely been studied explicitly. The available data indicates
the translation of all three DNMTs in the majority of
tissues, but translation levels seem to vary between tissues,
cell diﬀerentiation levels, host developmental stages and
potentially host species. Robertson et al. (23) analyzed
DNMT mRNA levels in various human tissues and found
DNMT1, 3a and 3b expressed in nearly all analyzed fetal
and adult tissues. In adult tissues, DNMT1 appeared to be
generally more highly expressed than DNMT3a and 3b,
and DNMT1 mRNA was detected in all analyzed tissues
except the small intestine. DNMT3a and 3b mRNAs were
detected in large quantities in heart, skeletal muscle,
thymus, kidney, liver and peripheral blood mononuclear
cells, but were present at low levels in all other analyzed
tissues. DNMT1 and 3a seemed to be expressed at high
levels in all analyzed fetal tissues, while DNMT 3b was
expressed at high levels only in fetal liver. The authors
proposed fetal hepatic hematopoiesis as the reason for the
observed high levels of DNMT3b in the fetal liver. In
bovine fetuses, Golding et al. (24) found DNMT3b highly
expressed in rumen, kidney, testes and lung while the
highest mRNA levels were again detected in the liver.
MessengerRNAs of all three DNMTs were again detected
in all of the adult bovine tissues analyzed, but highest
levels were detected in kidney, brain and testes. Mizuno
et al. (25) detected mRNAs for all three DNMTs in
human neutrophils, monocytes, T lymphocytes, bone
marrow cells and CD34-positive immune cells, but
mRNA levels varied between cell types. DNMT1
appeared to be expressed at high levels in all cell types
except neutrophiles, while DNMT3a mRNA levels in
neutrophiles and T lymphocytes appeared high. DNMT3b
mRNA levels were low in diﬀerentiated cells such as
neutrophiles, but high in bone marrow and particularly
CD34-positive cells.
Methylation patterns are generally stable, sustained by
DNMT1 and are inherited by both daughter DNA
molecules during mitosis. However, during meiosis both
parental genomes are demethylated prior to fertilization,
and cellular methylation patterns become established
de novo during embryogenesis. This process usually
starts during implantation and is ﬁnished by the end of
gastrulation (26). The development of site-speciﬁc methyl-
ation patterns is crucial for normal embryonic develop-
ment (27–29) and is responsible for genomic imprinting
and for X chromosome silencing (30,31).
Methylation-induced gene silencing
CpG methylation acts to suppress transcription in several
ways (32). It can directly prevent the binding of
transcription factors to the promoter regions of genes,
most likely due to steric hindrance. Alternatively, a
number of proteins, known as methyl-CpG binding
(MeCP) proteins, can selectively bind methylated CpG
sites. One of these, Kaiso, recognizes methylated CpG
sites through a zinc-ﬁnger motif, while another subgroup
shares a conserved methyl-CpG-binding domain (MBD).
The MBD proteins MBD 1, 2 and MeCP2, as well as
Kaiso, all function as transcriptional repressors. MBD 3,
however, associates with the nucleosome remodeling and
histone deacetylation (NuRD) complex, a co-repressor
complex containing histone deacetylases. Deacetylation of
histones increases their aﬃnity for DNA, leading to the
formation of inactive heterochromatin (30,33,34).
Methylation-induced silencing of foreignDNA
Methylation is involved in the inactivation of integrated
foreign DNA, such as retrotransposons, proviral
sequences and other transposable elements (TEs) (33).
These ‘parasitic’ DNAs constitute a quantitatively sig-
niﬁcant portion of mammalian genomes, comprising, for
example,  40% of the human genome. They are notably
GC rich and, within mammalian genomes, are hyper-
methylated at CpG motifs. In several studies, the
inhibition of de novo or maintenance methylation was
associated with increased transcription levels of TEs,
indicating that eﬀective TE silencing requires both de novo
and maintenance methylation, likely catalyzed by
DNMT3L and DNMT1, respectively (35,36).
Methylation andinnate immunity
CpG methylation also plays an important role in
immune surveillance and the detection of pathogens,
Table 1. Overview of vertebrate DNA methyltransferases and their functions
DNMT Functional role Reference
De-novo DNMTs
DNMT 3a Embryonic development, methylation of CpG sites, meiosis induction in sperm(?) (110–112)
DNMT 3b Embryonic development, spermatogenesis(?) (110,113)
DNMT 3L Maternal genomic imprinting, silencing of retrotransposons in spermatogonial stem cells (114)
Maintenance DNMTs
DNMT 1 Cellular maintenance methylation, maintenance of imprinting, silencing of mobile elements during
genomic demethylation, contribution to histone deacetylases
(115–118)
DNMT 2 Unclear. Methylation in Drosophila melanogaster(?) (119)
The enzymatic functions attributed to known DNMTs are summarized here, and some key references are provided. Some simpliﬁcations were made
for the purpose of clarity, and the reader is referred to speciﬁc reviews of DNMTs, indicated in the text, for more detail. Cases where the functional
role has been proposed, but not yet established conclusively, are indicated by question marks.
2826 Nucleic Acids Research, 2008, Vol. 36, No. 9as unmethylated CpGs are a signature of bacterial and
other pathogen-associated DNA. CpG-containing oligo-
deoxynucleotides (ODNs), even as short as 6nt in length,
can be potent stimulators of the vertebrate immune system,
resulting in the activation of a wide variety of immune cells
such as B cells, NK cells, monocytes/macrophages and
dendritic cells (DCs). Stimulation with CpG ODNs
directly activates plasmacytoid dendritic cells (PDCs) and
B cells. The PDCs secrete large amounts of IFN-a and
IL-12 which subsequently stimulate monocytes, myeloid
DCs, T cells and type-1 NK cells (37–39). One pathway
through which unmethylated CpGs trigger innate immune
responses is by binding a member of the Toll-like receptor
(TLR) family, TLR9 [see, as one example, (40)]. TLR9 is
expressed at high levels on subsets of human and mouse
DCs and gene homologs have been found in many other
mammalian species. The degree to which particular CpG
sequences stimulate immune responses depends upon their
ﬂanking nucleotide sequences, and motifs which confer
maximal stimulation are at least partially species-speciﬁc
(41). For example, ODNs containing the motif GACGTT
very eﬃciently stimulate murine and rabbit B cells, but
only weakly stimulate human B cells, which are most
eﬀectively stimulated by GTCGTT (42). Some similarities
in recognition sequences among related species appear
likely. For example, GTCGTT motifs are highly immune
stimulatory in a variety of vertebrates including humans,
dogs, cats, cows, chicken and nonhuman primates (41).
ODNs that are thymine rich at the 30 end and contain a
TpC dinucleotide at their 50 end appear to be generally
potent immune stimulators, while those that contain CpG
motifs toward the 30 end appear to be less immunogenic
(41). Generalities, however, may be misleading in some
cases, as resulting immune eﬀects are thought to be highly
cell-type and species speciﬁc (43–45).
CpG dinucleotides in vertebrate genomes are most
commonly preceded by a C and followed by a G (46), a
signature which does not appear to be immune stimula-
tory. Motifs such as TTCCGA, on the other hand, appear
to be potent stimulators of the human immune system and
may play a role in autoimmune diseases such as lupus
erythematosus. Other CpG motifs, for example those
containing poly(G) sequences, are thought to inhibit
NF-kB-induced immune stimulation (47). The relatively
low occurrence of stimulatory motifs in mammalian DNA
might explain the lower immunogenicity of unmethylated
vertebrate DNA compared to bacterial DNA.
Stimulatory motifs in DNA virus genomes. The genomes
of some, but not all, viruses are also lacking many such
stimulatory sequences. For example, likely stimulatory
sequences are highly underrepresented in the genomes of
adenovirus serotypes 2 and 5, but not in serotype 12.
Adenovirus type 2 and 5 can cause persistent infections,
their DNA is not immune stimulatory and it might even
suppress immune stimulation by DNA from other
sources. Type 12, however, does not cause persistent
infections, and its DNA appears highly immune stimula-
tory. Experimental evidence for a correlation between the
stimulatory potential of the viral DNA and the number of
supposedly stimulatory motifs has been presented (48).
Table 2 summarizes the frequencies of certain putatively
stimulatory and nonstimulatory motifs in genomes from
several members of diﬀerent viral families. General
conclusions are diﬃcult to draw since the biological eﬀects
of individual motifs likely diﬀer between virus families and
host species. Moreover, the limited genome size and CpG
underrepresentation complicates inference for small DNA
viruses. However, certain patterns appear noticeable even
without using formal statistical inference. The ratio of
total stimulatory to total nonstimulatory motifs is higher
than expected based on the viral nucleotide composition
for Frog adenovirus, Frog virus 3 and herpes simplex
virus type-1 (HSV1), while it is lower than expected for all
other viruses for which this value can be calculated.
Putatively stimulatory motifs are rarely present more
frequently than expected based on the viral nucleotide
composition, with the exception of HSV1 and Frog virus 3.
Putatively nonstimulatory motifs, on the other hand, are
present at higher frequency than expected in several cases,
as seen for several adeno- and herpesviruses. The driving
forces determining this nucleotide composition are diﬃ-
cult to disentangle. HSV1 induces mainly subclinical,
persistent and recurrent infections but HSV1 DNA has
been shown to eﬃciently stimulate TLR9 responses (49).
The mammalian genomes examined contain a functional
TLR9 ortholog, but chickens lack an orthologous TLR9
gene, and the same is likely true for most if not all avian
species. Unfortunately, data on other avian species are
thus far limited (50) and it is not known, in most cases,
whether amphibian species have a functional TLR9.
Several other factors likely inﬂuence presence and
distribution of CpG-containing motifs, but many of
these remain to be understood.
DNA VIRUSES AND CYTOSINE METHYLATION
To understand the impact of cytosine methylation on the
viral life cycle and the evolution of base composition, the
particularities of each virus will need to be considered.
Diﬀerences will inevitably exist between actively replicat-
ing viral DNA and that which is integrated into the host
genome. The type of viral persistence will also be of
importance. The integration of adeno- or polyomavirus
DNA into the host genome is usually a terminal process
since the viruses cannot liberate their genomes and are
therefore no longer infectious. The evolutionary roles of
methylation in these cases will likely diﬀer from those seen
in other viruses, such as Herpesviruses, which can liberate
their genome after periods of latency. But diﬀerences may
also exist between large and small viruses—with many
larger viruses encoding their own replication machinery
and additional proteins which modify host cell processes
and immune responses. The susceptibility of the viral
genome to methylation and immune recognition will also
be aﬀected by other factors, such as the location of
replication within the cell and the speciﬁc intracellular
traﬃcking route (Figure 1).
Viruses that integrate into the host genome and the
eﬀects of methylation on their life cycles have long been
of particular interest. Many studies have focused on
Nucleic Acids Research, 2008, Vol. 36, No. 9 2827Table 2. Frequency of TLR9 stimulatory and non-stimulatory/inhibitory sequences
Virus Host Base frequencies Stimulatory Non-stimulatory
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Small ss DNA viruses
FPV Cat 1816 (35.44) 835 (16.3) 1036 (20.2) 1437 (28.04) 76 (169) 167 (169) 0.455 (1) 0 (1) 0 (1) 0 (1) 0 (3) 0 (1) 2 (0) 0 (0) 2 (1) – (3) 5124 M38246 #
CPV Dog 1923 (35.92) 839 (15.76) 1054 (19.8) 1507 (28.3) 74 (166) 161 (166) 0.46 (1) 0 (1) 0 (1) 0 (1) 0 (3) 0 (1) 1 (0) 0 (0) 1 – (3) 5323 NC_001539
AAV1 Human 1121 (23.76) 1393 (29.52) 1273 (26.98) 931 (19.73) 316 (376) 383 (276) 0.825 (1) 1 (1) 0 (1) 0 (1) 1 (3) 0 (1) 5 (2) 1 (3) 6 (6) 0.167 (0.5) 4718 NC_002077
AAV2 Human 1198 (25.6) 1262 (26.97) 1255 (28.82) 964 (20.6) 266 (364) 304 (364) 0.875 (1) 2 (1) 0 (1) 0 (1) 2 (3) 1 (1) 4 (2) 0 (2) 5 (5) 0.400 (0.6) 4679 NC_001401
AAV4 Human 1137 (23.85) 1405 (29.47) 1333 (27.96) 892 (18.7) 325 (392) 368 (392) 0.883 (1) 0 (1) 0 (1) 0 (1) 0 (3) 1 (1) 4 (3) 1 (3) 6 (7) – (0.429) 4767 NC_001829
AAV5 Human 1167 (25.14) 1322 (28.48) 1238 (26.67) 915 (19.7) 287 (352) 320 (352) 0.897 (1) 0 (1) 0 (1) 0 (1) 0 (3) 1 (1) 1 (2) 1 (2) 3 (5) – (0.6) 4642 NC_006152
Small ds DNA viruses
SV40 Human 1518 (28.95) 1100 (20.98) 1039 (19.82) 1586 (30.25) 27 (218) 266 (218) 0.102 (1) 0 (1) 0 (1) 0 (1) 0 (3) 0 (1) 0 (1) 0 (0) 0 (0) – (3) 5243 NC_001669
JC polyoma-
virus
human 1527 (29.77) 1035 (20.18) 1040 (20.27) 1528 (29.79) 16 (210) 255 210) 0.063 (1) 0 (1) 0 (1) 0 (1) 0 (3) 0 (1) 0 (0) 0 (0) 0 (1) – (3) 5130 NC_001699
Murine
polyoma-
virus
Mouse 1396 (26.36) 1270 (23.98) 1233 (23.29) 1398 (26.4) 94 (295) 289 (295) 0.325 (1) 0 (1) 0 (1) 1 (1) 1 (3) 0 (1) 0 (1) 0 (1) 0 (3) – (0.5) 5295 NC_001515
Large ds DNA viruses
HSV1 Human 24240 (15.92) 51458 (33.79) 52513 (34.49) 24050 (15.79) 17917 (17745) 16465 (17745) 1.088 (1) 31 (24) 37 (24) 49 (52) 117 (100) 24 (24) 236 (241) 297 (236) 557 (501) 0.21 (0.1996) 152261 NC_001806
Gallid
herpes-
virus 1
Chicken 38272 (25.74) 35807 (24.08) 35798 (24.08) 38810 (26.1) 8666 (8622) 9401 (8622) 0.922 (1) 25 (37) 22 (37) 31 (34) 78 (108) 45 (36) 74 (29) 40 (29) 159 (94) 0.49 (1.148) 148687 NC_006623
Human
adeno-
virus D
Human 7988 (22.76) 9877 (28.14) 9981 (28.44) 7250 (20.66) 2410 (2808) 3034 (2808) 0.794 (1) 1 (7) 2 (7) 8 (10) 11 (24) 2 (8) 36 (18) 22 (18) 60 (40) 0.183 (0.6) 35096 NC_002067
Simian
adeno-
virus 1
Non-human
primate
7939 (23.04) 9677 (28.09) 9343 (27.11) 7491 (21.75) 2327 (2623) 2703 (2623) 0.861 (1) 3 (8) 7 (7) 10 (10) 20 (25) 6 (8) 11 (15) 19 (16) 36 (39) 0.556 (0.64) 34450 NC_006879
Fowl
adeno-
virus A
chicken 10284 (23.48) 12087 (27.59) 11699 (26.71) 9734 (22.22) 3332 (3228) 3109 (3228) 1.072 (1) 11 (10) 10 (10) 9 (12) 30 (32) 15 (11) 27 (18) 19 (18) 61 (47) 0.492 (0.68) 43804 NC_001720
Fowl
adeno-
virus D
Chicken 10485 (23.27) 12305 (27.3) 11931 (26.48) 10342 (22.95) 3857 (3258) 3178 (3258) 1.214 (1) 10 (11) 11 (10) 11 (12) 32 (33) 17 (11) 15 (17) 32 (18) 64 (46) 0.5 (0.72) 45063 NC_000899
Frog adeno-
virus
Frog 7827 (29.9) 4693 (17.94) 5210 (19.91) 8433 (32.23) 509 (1011) 1017 (1011) 0.500 (1) 2 (6) 3 (7) 3 (4) 8 (17) 0 (6) 3 (1) 0 (1) 3 (8) 2.667 (2.1) 26163 NC_002501
Frog virus 3 Frog 24269 (22.92) 28815 (27.2) 29488 (27.84) 23331 (22.03) 5633 (8020) 6342 (8020) 0.888 (1) 31 (25) 14 (24) 11 (29) 56 (78) 10 (24) 7 (46) 25 (44) 42 (114) 1.333 (0.68) 105903 NC_005946
GpC and CpG contents, as well as individual nucleotide and motif frequencies, were determined from the publicly available reference sequences (RefSeq) in Genbank (MatLab script available from the authors upon request). Sequence
length, frequencies and percentages of individual nucleotides, GpC and CpG content, as well as the frequencies of potentially stimulating and non-stimulating motifs, are provided.
Potentially stimulatory sequences are those described by Rankin et al. (120); values represent the total number of the respective motif present in the genome. The number in parentheses indicates the number of motifs expected in the
sequence, given the individual nucleotide composition. This was calculated using the following formula: E(UVWXYZ)=10
 12  sequence length (%U %V %W %X %Y %Z), where E(UVWXYZ)=expected value of the motif
UVWXYZ; U,V,W,X,Y,Z=nucleotides of which the motif consists, and %U=% of viral sequence consisting of base U. Expected values were rounded to the nearest integer. Likely non-stimulatory and potentially inhibitory sequences are
those described by Krieg; values again represent the total number of the respective motif present in the genome, and expected values were calculated as describe above. ‘Total stimulatory’ or ‘total non-stimulatory’ values represents the sum
of all putatively stimulatory or non-stimulatory motifs in the sequence. ‘Ratio of stimulatory/non-stimulatory sequences’ represent the fraction of the total number of stimulatory divided by the total number of non-stimulatory sequences.
‘CpG’ or ‘GpC’ represents the total number of the respective dinucleotide CpG or GpC in the viral DNA sequence. ‘CpG/GpC’ represents fraction of the number of CpG motifs divided by the number of GpC motifs in the viral DNA.
‘RefSeq’ number represent GeneBank accession number. ‘#’ no RefSeq FPV sequence available.adenoviruses, but comprehensive knowledge of the
methylation status of other viruses, such as polyoma-
viruses and herpesviruses, has also been obtained
(Table 3).
Early studies of viral methylation focused on DNA
from polyomavirus-infected cells (51). The early methods
(e.g. quantiﬁcation of methyl-H
3 incorporation into the
genome) used to measure methylation were limited in their
sensitivity and did not show the genomic distribution of
methylated sites. Technical advances later made it possible
to study cytosine methylation in a more detailed and site-
speciﬁc manner. However, the various roles of methyla-
tion during persistent viral infections, in the silencing of
viral genomes, and in immune evasion and tumor
formation are still being uncovered.
The impact of methylation during active viral replica-
tion is generally incompletely understood, and for many
small DNA viruses it is currently not known whether the
viral genome is methylated during active replication.
Adenovirus DNA methylation: summarizing technical
advances in viralmethylation studies
Early studies of adenovirus methylation relied on chro-
matographic and radioactive techniques to distinguish
methylated from unmethylated bases. The techniques were
complicated by limited sensitivity, the diﬃculty of isolat-
ing pure viral fractions and the inability to discriminate
between host and integrated viral DNA. The investigators
nevertheless carefully compared actively replicating and
integrated viral DNA and their conclusions have stood
the test of time. Genomic DNA from adenovirus type 2
and 12 infected cells was heavily methylated, more than
cellular DNA from uninfected control cells (52). Whether
the integration of viral DNA altered methylation patterns
in the host genome or whether the observed diﬀerences
were due exclusively to the integrated viral DNA was not
determined. However, actively replicating adenovirus type
2 and 12 DNA appeared to have few or no methylated
bases (52).
More sensitive analysis was allowed by pairs of
methylation-sensitive and insensitive restriction endonu-
cleases. In particular, the isoschizomers HpaII and MspI
have been used frequently in studies of DNA methylation.
Both enzymes recognize the motif CCGG, but the
catalytic activity of HpaII is inhibited by CpG methyla-
tion while the activity of MspI is not aﬀected. The new
technique veriﬁed the previous results with actively
replicating adenovirus type 2 and 12 DNA showing
no detectable methylated CCGG sites and the restric-
tion patterns were consistent among viral DNAs from
Figure 1. Comparison of DNA virus infection pathways. Major intracellular traﬃcking routes and characteristics of replication are shown for the
DNA virus families discussed. The importance of methylation and immune recognition is indicated. Simpliﬁcations and generalizations were made
for the purpose of clarity.
Nucleic Acids Research, 2008, Vol. 36, No. 9 2829Table 3. Overview of GC content, CpG frequency and methylation status of small and large DNA viruses
Virus Genome
size
a (kb)
GC
frequency
a
CpG
content
a
(rCPG)
Methylation status during
active replication
Methylation status during latency Host species Eﬀect on host methylation
Replicating Reference
b Integrated Episomal Reference
b
Large dsDNA viruses
Adenoviridae 28–45 0.3–0.65 0.5–1.13 Un/hypomethylated (121) Methylated – (121) Mammal, bird DNMT upregulation
Alpha-herpesvirinae 130–150 0.4–0.71 0.9–1.17 Un/hypomethylated (67) – Un/hypo-
mehtylated
(89) Mammal, bird DNMT upregulation
Beta-herpesvirinae 140–240 0.4–0.67 1.0–1.25 Unknown N/A – Unknown N/A Mammal Unknown
Gamma-herpesvirinae 110–185 0.3–0.61 0.3–0.66 Un/hypomethylated (66) – Methylated (65) Mammal DNMT upregulation
(122)
Ranid herpesvirus
c 220–230 0.5–0.55 0.8–0.95 Methylated (70) – Unknown N/A Amphibian Viral 5-cytosine
methyltransferases?
Iridoviridae 140–383 0.2–0.56 0.5–0.84 Methylated (74) – – – Amphibian, ﬁsh Viral 5-cytosine
methyltransferases?
Poxviridae 130–375 0.2–0.64 0.8–1.23 Unknown N/A – – – Mammal bird
invertebrate
Unknown
Small dsDNA viruses
Papilloma-viridae 7–8 0.4–0.54 0.1–0.57 Partially methylated (60) Methylated – (123) Mammal DNMT upregulation
Polyoma-viridae 5 0.4–0.48 0.05–0.78 Un/hypomethylated (51) Methylated – (51) Mammal, bird DNMT upregulation
Small ssDNA viruses
Autonomous Parvoviridae 4–6 0.3–0.5 0.3–0.71 Unknown N/A – – – Mammal Unknown
Dependo-virinae 4–6 0.4–0.58 0.6–1.03 Unknown N/A – – – Mammal Unknown
Circoviridae 2 0.5–0.57 0.4–0.87 Unknown N/A – – – Mammal, bird Unknown
Anellovirus 4 0.5 0.67 Unknown N/A – – – Human Unknown
The GC content, CpG content and, where known, methylation status is shown for viral families/subfamilies. Where applicable, a distinction is made between active replication and latency.
If latent, the state of the genome (i.e. integrated or episomal) is speciﬁed. Preferred host species are indicated along with any known eﬀect the virus has on host cell methylation. Where relevant,
representative references are provided.
Dash indicates this form is not known to occur for this virus.
aGC and CpG contents as determined by authors [here or in (83)] according to methods described therein); GC content represents the relative frequency of G and C in the sequence. CpG content
represents the observed divided by the expected frequency of the dinucleotide CpG in the sequence.
bReference refers to a representative study, which focuses on one member of the virus family.
cUnpublished results, analysis done by authors as described above (83).
2
8
3
0
N
u
c
l
e
i
c
A
c
i
d
s
R
e
s
e
a
r
c
h
,
2
0
0
8
,
V
o
l
.
3
6
,
N
o
.
9diﬀerent cells (53). Inference from restriction enzyme
analyses, however, remained limited to those sites
recognizable by restriction enzyme pairs. Several subse-
quent studies focused on adenovirus DNA and the
absence of methylated sites could later be conclusively
established through bisulfate sequencing (51–53). Bisulfate
converts unmethylated cytosines to thymines and thus
allows the sensitive detection of speciﬁc methylated sites
by sequencing the genome prior to and after treatment.
The absence of methylated sites in the replicating
adenovirus 2 genome has been shown using this technique
(54–56).
Many studies of adenovirus DNA have focused on
integrated viral genomes or genomic segments, largely
because of their oncogenic potential. Integrated adeno-
viral DNA is known to be hypermethylated, but the
regulatory events which determine the methylation status
of replicating or integrated sequences are not well under-
stood. A recombinant between adenovirus 12 and host cell
DNA (referred to as SYREC) is unmethylated over the
whole genome during active replication including the
host-derived sequence, which is methylated in the chro-
mosome. This led to speculations about the existence of
adenovirus-encoded de-methylation proteins, or a role for
the virus-encoded replication machinery in methylation
avoidance (57). However, no speciﬁc mechanisms have
been deﬁned, and the speed of viral replication or
compartmentalization of this process within the host cell
has also been proposed as factors contributing to the lack
of methylation.
Methylation statusof polyoma- and papillomaviruses
Studies of papovavirus DNA methylation also focused on
integrated sequences, mostly of human papillomavirus
strains and SV40 polyomavirus. Polyomavirus and
papillomavirus genomes are CpG-depleted (Table 3) and
any CpG motifs present are clustered within certain
regions of the viral genome (58), complicating the analysis
of methylation patterns. The early studies, however,
concluded that there was little methylation in replicating
polyomaviruses (51), with the possible exception of a CpG
site near the early promoter (59). Several other studies
concurred and found several human papillomavirus
strains to be hypomethylated during active replication,
again with methylated sites clustering in speciﬁc regions of
the viral genome. The integrated viral DNA, on the
contrary, appeared heavily methylated. However, distin-
guishing between actively replicating and integrated DNA
appears diﬃcult in some cases (60–62).
Methylation statusof herpesvirus genomes
Herpesviruses establish latent infections without integrat-
ing into the host genome, and reactivate to re-establish
active replication. During latency, the circularized viral
genome remains quiescent in an episomal state, and can be
replicated by the host cell replication machinery. Active
(e.g. lytic) viral replication diﬀers in several respects.
Production of viral progeny inevitably results in cell lysis,
utilizes the viral-encoded replication machinery and
involves a separate origin of replication [e.g. in the case
of Epstein–Barr Virus (EBV) oriLyt functions as the origin
of replication in the lytic cycle while oriP is responsible for
replication of episomal EBV DNA (63)]. The methylation
status during lytic DNA replication is likely diﬀerent from
that during latency, but most studies have focused on
latent infections and the diﬀerences have rarely been
studied explicitly.
Diﬀerences might also exist among herpesvirus sub-
families, as CpG motifs are highly underrepresented in
gammaherpesvirus genomes, but not in alpha- or beta-
herpesvirus genomes (64). The reasons for these diﬀer-
ences remain elusive. Gammaherpesviruses cause
predominantly persistent, lymphoproliferative diseases.
Studies of some gammaherpesviruses, such as EBV and
Kaposi’s Sarcoma-associated herpesvirus (KSHV), indi-
cate that methylation serves an intricate regulatory role
during the viral life cycle (see below). The EBV genome
appears to be hypomethylated or unmethylated during
lytic infection, but highly methylated during latency, and
appears to become demethylated during reactivation (65).
There is some evidence for methylation during active
replication of another gammaherpesvirus, herpesvirus
saimiri, since Kaschka-Dierich et al. (66) found both the
linear and circular viral DNA to be heavily methylated.
The alphaherpesvirus herpes simplex virus (HSV) appears
unmethylated during active replication and latency
(67–69) while two frog herpesviruses (ranid herpesvirus
1 and 2) appear to be methylated during replication. The
ranid herpesvirus genomes also contain putative DNA
cytosine-5 methyltransferases sequences located in ORFs
86 and 120 (70).
Methylation plays a pivotal role in the life cycle of EBV
(71,72), where methylation of speciﬁc genes appears to be
involved in the transition from lytic to latent infection.
Most EBV nuclear antigens (EBNAs) are expressed only
for short periods during the lytic infection, after which
their transcription is silenced through hypermethylation
of the viral promoters Cp and Wp. Production of the
indispensable EBNA1 is then achieved by expression from
an alternative ‘TATA-less’ promoter Qp. Reinitiation
of lytic infection can occur spontaneously or may be
triggered by events such as immunoglobulin crosslinking
of the host cell and cell proliferation. Reactivation is
mediated through the expression of the immediate early
genes Zta and Rta, which are regulated by the promoters
Zp and Rp, the latter of which is hypermethylated during
latency. While Rp hypermethylation is a major regulator
of latent infection, Zp hypermethylation is dispensable.
EBV therefore seems to use methylation-induced gene
silencing as an immune evasion strategy. While a role for
methylation in the EBV lifecycle is widely accepted, its
importance for other herpesviruses is still disputed.
Methylation status ofiridiviruses and ascoviruses
The genomes of iridoviruses appear to be heavily
methylated during active replication and methylation
might again have a regulatory role. Iridoviruses are large
DNA viruses that infect ﬁsh, amphibians and reptiles.
Initial stages of replication occur in the nucleus, after
which the nascent viral genomes are transported into
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(73). Willis and Granoﬀ (74) analyzed the iridovirus frog
virus 3 (FV3) by radioactive labeling/restriction enzyme
digestion and found the viral DNA to be heavily
methylated, with an estimated 20% of cytosines methyl-
ated. Time-course experiments later indicated changing
methylation patterns over the course of infection. Willis
et al. (75) analyzed nuclear and cytoplasmic extracts
collected at various times postinfection (p.i.) and found
methylated viral DNA after  6–7h p.i. This DNA
appeared to be located in the cytoplasm, while nuclear
DNA, collected at earlier time points, appeared to be
hypomethylated. The authors also provided evidence
against demethylation of parental viral genomes upon
host cell infection. Further, Schetter et al. (76) showed that
nascent FV3 DNA in the nucleus is unmethylated or
hypomethylated at early times p.i, but later becomes
hypermethylated (after  6h p.i. in their assay).
Cytoplasmic viral DNA, on the other hand, appears to
be methylated at all times. The authors reported DNA
methyltransferase activity in nuclear extracts of FV3
infected cells, beginning at a time p.i. which coincided
with the appearance of methylated viral genomes. This
activity was absent from cytoplasmic extracts, indicating
FV3 might regulate methylation of its genome. It was
later discovered that the FV3 genome encodes a putative
DNA cytosine-5 methyltransferase sequence, which bears
similarities to other known methyltransferases (77). The
putative methyltransferase, however, is more homologous
to prokaryotic enzymes than to eukaryotic methyltrans-
ferases. While transcription (from an early promoter) and
translation of this FV3 protein have been veriﬁed, direct
evidence for its methylation activity is still limited.
Another iridovirus, ﬁsh lymphocystis disease virus
(FLDV), was also found to have a highly methylated
genome, even though its GC content is considerably lower
than that of FV3 (78,79). FLDV also contains a putative
5-cytosine methyltransferase (53.3% identical to that of
FV3) (80) but evidence for its function is, thus far,
scarce. Besides the frog herpesviruses and iridoviruses,
ascoviruses, which infect insects and are closely related
to the iridoviruses, are also heavily methylated during
replication (81).
Methylation status ofsmall DNA viruses
In contrast to most large DNA viruses, CpG is under-
represented in the majority of small DNA viruses
(64,82,83). It is possible that cytosine methylation is
partly responsible for this underrepresentation. Small
DNA viruses encode only a minimal number of proteins
and use the host cell replication machinery for replication.
Low CpG frequencies may have been selected to avoid
methylation by host methyltransferases, to maximize
translation eﬃciencies, or as a means of reducing CpG
mediated immune responses. However, apart from the
small polyomaviruses and papillomaviruses described
above, there appears to have been few close examinations
of the methylation status of small DNA viruses (particu-
larly those that do not integrate), such as autonomous
parvoviruses, circoviruses and anelloviruses. The roles and
eﬀects of methylation might be diﬀerent from those seen in
integrating and/or large DNA viruses, but further research
is needed to understand the speciﬁc eﬀects of methylation
on small, nonintegrating DNA viruses.
Adeno-associated virus (AAV) integrates into the host
genome, and has been examined primarily in the context
of guanine methylation. Productive infection with an
AAV normally requires co-infection with a helper virus
(usually an adenovirus or, less frequently, a herpesvirus).
In the absence of a helper virus, AAVs may remain in the
cell as persistent dsDNA, or they may be stably integrated
into the host genome. Upon infection by a helpervirus, the
integrated AAV DNA can be rescued and undergo active
replication. The CpG contents of AAVs more closely
resemble those of their helper viruses than those of the
closely related autonomous parvoviruses, which show
strong CpG suppression. The mechanisms of integration
have been extensively studied in AAV serotype 2 (AAV2),
which predominantly integrates in a speciﬁc region of
chromosome 19 (locus 19q13.3t). Integration is directed
by AAV-encoded Rep proteins, which likely recognize
guanine residues within GCTC repeating motifs (located
in the AAV terminal hairpin). In vitro methylation of these
guanine residues has been shown to eﬀectively inhibit
DNA–protein interactions and likely interferes with
integration in vivo (84). Similar results were obtained
when examining the integration of AAV4 (which utilizes a
slightly diﬀerent recognition motif) into African green
monkey cells (85). Nevertheless, it is not known what role,
if any, cytosine-5 methylation plays in the natural AAV
life cycle, if AAV methylation inﬂuences integration, or if
guanines or cytosines are methylated during active
replication.
METHYLATION AND INTEGRATED OR LATENT
VIRAL DNA
Methylation of integrated viral DNA has been studied
extensively and the topic is extensively covered in the
scientiﬁc literature. Areas of interest have included
changes in methylation patterns during integration, the
eﬀects of viral methylation on host cells and the
correlation between virally induced methylation and
tumor formation. Excellent reviews have been published
on these topics and the reader is referred to these
articles, indicated in the following discussion, for addi-
tional detail. Here we brieﬂy summarize what is known
about methylation during integration and latency and the
regulatory elements involved, contrasting the level of
understanding to what is known about methylation during
active replication.
As already mentioned above, most DNA viruses such
as adenoviruses (57,59,86–88) and polyomaviruses (83)
appear speciﬁcally methylated during latency or when in
an integrated form. In contrast, the alphaherpesvirus HSV
does not appear to be methylated during latency (89), but
the reasons for this diﬀerence are unclear. The processes
by which integrating viruses are de novo methylated are
only partly understood, but it is clear that the extent and
pattern of de novo methylation depend upon the time after
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sequences (90–94), and possibly the cell type (57,90).
De novo methylation tends to be initiated within conﬁned
genomic regions and then spreads throughout the viral
genome (90,93,95,87). For example, in a study examining
the methylation pattern of adenovirus 12 over the course
of integration into hamster cells, methylation began in the
center of the viral DNA (between map units 30 and 75)
and subsequently spread outward in both directions. Some
regions of the viral genome remained unmethylated
throughout the study, namely the right terminal repeat
and regions near the left terminus (95). It is not known
which factors initiate methylation of the genome, nor the
determinants of the sequential methylation pattern.
Methylation patterns appear to be site speciﬁc. In many
viruses there seems to be an inverse correlation between
viral gene expression and degree of methylation, with late
viral genes being generally more susceptible to methyla-
tion eﬀects than early genes (53,91). Promoter regions of
integrated viruses are frequently hypomethylated. For
example, promoter regions in adenovirus 12 are hypo-
methylated at CCGG sites while the viral genome is
otherwise heavily methylated (57,59,96). Methylation of
viral genes, particularly at promoter sequences, appears to
be a reversible event (96) but the mechanism by which
viral genomes are demethylated remains to be determined.
Demethylation has also been shown to occur after in vitro
methylation of several viral DNAs. For example,
SV40 DNA recovered 20h after microinjection into cells
retained the artiﬁcial methylation pattern under nonper-
missive culture conditions, while allowing early gene
transcription. The DNA, however, became demethylated
after viral replication (97). Loss of methylation has also
been observed in adenoviruses, in the case of the SYRECs
mentioned above (86,98) which are methylated when
covalently linked to the host genome, but unmethylated
during active replication. They require the presence of
fully functional adenovirus helper for eﬃcient lytic
replication, which led some to postulate a role for the
viral transcription machinery in the loss of methylation.
Unfortunately, experimental data in support of this
hypothesis are so far scarce.
Infection with integrating (and even some nonintegrat-
ing) viruses can induce alterations in the methylation
patterns of host DNA, a potential factor in the develop-
ment of malignant tumors. For example, herpesviruses
KSHV and EBV, polyomaviruses BK and SV40, papillo-
mavirus HPV, several adenoviruses and hepatitis B virus
encode proteins that activate/upregulate DNMT1, 3a, or
3b. This results in the hypermethylation and, therefore,
the downregulation of a number of cellular genes. One of
the cellular genes frequently hypermethylated in these
infections is the cell cycle regulating tumor suppressor
gene p16INK4a, which is commonly hypermethylated in
many types of cancer (99). Diﬀerentiation of host cell
tumors and the level of genome methylation of integrated
viruses generally appear to be positively correlated, as
seen for various papillomaviruses such as Shope papillo-
mavirus (100) and human papillomavirus (HPV)
(101,102), the herpesvirus EBV (72,103) and various
adenoviruses (96).
METHYLATION AND VIRAL GENE EXPRESSION
For iridoviruses, gene expression at functional levels
can be maintained despite genome hypermethylation.
Methylated sites, however, are not distributed randomly
across the genome and methylation levels diﬀer among
CpG motifs. FLDV, for example, has a considerably
higher level of methylation at CCGG than CGCG motifs
(79). The physiological signiﬁcance of this, however, is still
disputed. In vitro studies of the related FV3 showed that
speciﬁc methylation (using HpaII methyltransferase) of
CCGG motifs in a late promoter, L1140, abolished its
function. However, the methylation of all CpG sites by the
indiscriminate SssI methyltransferase or the speciﬁc
methylation of GCGC motifs by HhaI methyltransferase
had no dramatic eﬀect. This appears to be a rare example
where, counterintuitively, complete methylation of a late
promoter does not abolish its function (methylation
frequently abolishes the function of late viral promoters,
while early promoters tend to be less susceptible to the
repressive eﬀect of cytosine methylation). The underlying
mechanism has not been elucidated, but steric hindrance
in asymmetrically methylated DNA might play a role
(104). It seems possible that methylation of CCGG motifs
results in complex secondary structures in the promoter
region, whereas indiscriminant CpG methylation or
methylation of GCGC motifs balances these secondary
structures. A similar phenomenon was seen in adenovirus
type 2, where methylation of CCGG sites within the (late)
E2a promoter inhibited the transcription of viral DNA,
while methylation of GCGC motifs had no repressive
eﬀect (105,106). The transcription activity of the poly-
omavirus SV40 was found not drastically decreased
when in vitro methylated with indiscriminant DNMTs
from rat liver (107,108). In contrast, upon speciﬁc
methylation of HpaII sites (CCGG-speciﬁc), transcription
activity was reduced markedly (59). However, the inter-
pretation of these latter results is complicated by the
possibility of incomplete methylation by the rat liver
extract, as rat liver DNA is a competitive inhibitor of
adenovirus methylation (55) and low-level contaminants
might likewise have inhibited complete methylation
of SV40.
In vitro methylation studies involving human papillo-
mavirus type 16 (HPV16) showed that indiscriminate SssI
methylation signiﬁcantly decreased the transcriptional
activity of the long control region (LCR), which is
devoid of ORFs but contains several cis-acting regulatory
elements. Enhancers located in the LCR are responsive to
both cellular and viral factors, such as the viral E2 gene
products. Transcriptional silencing was measured using an
LCR-containing reporter plasmid and inhibition was
again believed to be steric, speciﬁcally due to interference
with the binding of transcription regulator E2. Notably,
hypomethylation of HPV16 E2-binding sites has been
observed in highly diﬀerentiated, but not in undiﬀeren-
tiated, tumor cells (101). However, direct comparison of
the HPV16 and SV40 studies is diﬃcult. The eﬀects of
indiscriminate methylation on early and late viral gene
products in the genomic context are hard to infer from
this study.
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of methylation in several viruses. For example, the in vitro
HpaII (CCGG-speciﬁc) methylation of SV40 early genes
(i.e. those coding for the large T-antigen) does not lead to
transcriptional repression, and the in vitro methylated sites
are subsequently lost during active replication (108). Late
viral gene expression, however, can be eﬃciently inhibited
by in vitro methylation of HpaII sites within the 50 part of
this region (109). Site-speciﬁc methylation might be
involved in the transition to latency in some cases (as in
the case of EBV). On the other hand, methylation does not
seem to be involved in the switch from early to late gene
expression in HSV (89). Likewise, the major late promoter
of adenovirus 2, which induces the switch from early to
late gene expression, is unmethylated in nonintegrated
viruses (56), suggesting methylation does not play a major
role in the regulation of early versus late gene expression
for this virus.
CONCLUSIONS
A number of studies show that CpG methylation can
greatly aﬀect the life cycles of DNA viruses, but its exact
role in natural infections remains unclear. Those eﬀects
likely diﬀer between diﬀerent viruses and are dependent
upon many factors, such as the stage in the viral life cycle,
the host species and infected tissue, the ﬂanking nucleotide
motifs, the genes in question and the genomic location.
Where it has been studied, major diﬀerences have been
seen for some viruses between the actively replicating and
the latent or integrated viral DNA; the former is often
unmethylated or hypomethylated, while the later often
shows speciﬁc and regulated methylation. Diﬀerences may
also exist between large and small DNA viruses,
potentially because of their rate and site of replication
and diﬀerences in their ability to manipulate the host
responses to unmethylated DNA. Thus, it is necessary to
not only examine individual viruses, but to examine their
dynamic methylation status and the eﬀects of any viral
methylation on both the virus and the host cell. The
various ways in which mutational bias, codon usage and
host selections (e.g. through TLR9-dependent responses)
inﬂuence CpG frequency and methylation status need to
be deﬁned. It will be especially important to determine the
unique roles and regulators of methylation, and their
divergent eﬀects on the genome evolution of small and
large DNA viruses during active or latent infection, and in
packaged, integrated or episomal DNA. A deeper knowl-
edge of the relationships among the virus, the host cell and
methylation (and de-methylation) machinery will provide
essential insights into determinants of methylation status,
gene expression, replicative behavior, as well as activation
of pattern recognition receptors and immune responses.
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